Programmable control of co-stimulatory molecule and cytokine density at the immune synapse, combined with high-throughput screening and PhenoGraph visualization, may identify configurations that reduce donor response heterogeneity.
Authors: Jinchun Wang, Siddharth Subham, Andres Campos, Ayomide Oloyede, Javi Bravo-Alegria, Colleen M O’Connor, Andries Zijlstra
StimulusBio at the American Society of Gene & Cell Therapy on May 2026
in Boston, MA
Download the Full Poster Below
Contact StimulusBio to Talk About Your Scientific and Commercial Product Needs
In the competitive landscape of life science tools and diagnostics, even groundbreaking innovations struggle to gain traction and achieve widespread adoption. At StimulusBio, we specialize in empowering these vital technologies to reach their full potential. With our proven commercialization strategies and deep industry expertise, we partner with you at every stage to optimize your product’s marketability, reliability, and profitability – setting you up for lasting success in the marketplace.
